SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
TITAN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware 94-3171940
(State of incorporation or organization (I.R.S. employee identification no.)
400 Oyster Point Boulevard, Suite 505,
South San Francisco, California 94080
(Address of principal executive offices) (zip code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange On Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
Common Stock, $.001 par value Pacific Stock Exchange
Class A Warrants Pacific Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act: None
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered.
The information called for by this Item 1 is incorporated herein by
reference from the Registrant's Registration Statement on Form SB-2
(File No. 33-99386) filed with the Securities and Exchange Commission
on November 16, 1995.
Item 2. Exhibits
None.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: September 9, 1997 TITAN PHARMACEUTICALS, INC.
By: /s/ Robert E. Farrell
------------------------------
Robert E. Farrell
Chief Financial Officer
-3-
